LexAurum Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Sell |
5,639
-155
| -3% | -$10.7K | 0.06% | 228 |
|
|
2025
Q1 | $393K | Sell |
5,794
-133
| -2% | -$9.01K | 0.08% | 225 |
|
|
2024
Q4 | $266K | Buy |
5,927
+83
| +1% | +$3.73K | 0.05% | 280 |
|
|
2024
Q3 | $367K | Buy |
5,844
+10
| +0.2% | +$629 | 0.08% | 210 |
|
|
2024
Q2 | $345K | Buy |
5,834
+31
| +0.5% | +$1.83K | 0.08% | 206 |
|
|
2024
Q1 | $463K | Sell |
5,803
-983
| -14% | -$78.4K | 0.12% | 160 |
|
|
2023
Q4 | $536K | Buy |
6,786
+599
| +10% | +$47.3K | 0.14% | 145 |
|
|
2023
Q3 | $432K | Sell |
6,187
-5
| -0.1% | -$349 | 0.13% | 158 |
|
|
2023
Q2 | $428K | Buy |
6,192
+1,233
| +25% | +$85.2K | 0.13% | 149 |
|
|
2023
Q1 | $368K | Sell |
4,959
-94
| -2% | -$6.99K | 0.12% | 156 |
|
|
2022
Q4 | $471K | Buy |
5,053
+104
| +2% | +$9.69K | 0.17% | 124 |
|
|
2022
Q3 | $472K | Buy |
4,949
+159
| +3% | +$15.2K | 0.18% | 120 |
|
|
2022
Q2 | $444K | Buy |
4,790
+4
| +0.1% | +$371 | 0.17% | 128 |
|
|
2022
Q1 | $484K | Sell |
4,786
-96
| -2% | -$9.71K | 0.16% | 128 |
|
|
2021
Q4 | $504K | Buy |
4,882
+4
| +0.1% | +$413 | 0.16% | 134 |
|
|
2021
Q3 | $414K | Buy |
4,878
+290
| +6% | +$24.6K | 0.12% | 185 |
|
|
2021
Q2 | $383K | Buy |
4,588
+605
| +15% | +$50.5K | 0.11% | 195 |
|
|
2021
Q1 | $300K | Sell |
3,983
-220
| -5% | -$16.6K | 0.1% | 200 |
|
|
2020
Q4 | $287K | Sell |
4,203
-193
| -4% | -$13.2K | 0.1% | 190 |
|
|
2020
Q3 | $257K | Sell |
4,396
-605
| -12% | -$35.4K | 0.11% | 187 |
|
|
2020
Q2 | $325K | Buy |
5,001
+131
| +3% | +$8.51K | 0.18% | 128 |
|
|
2020
Q1 | $289K | Buy |
4,870
+158
| +3% | +$9.38K | 0.2% | 113 |
|
|
2019
Q4 | $350K | Buy |
4,712
+1,212
| +35% | +$90K | 0.17% | 134 |
|
|
2019
Q3 | $221K | Buy |
+3,500
| New | +$221K | 0.13% | 168 |
|